Proteomic Signatures of Vulnerability Across Late-Life Depression, Frailty, and Neurodegeneration

Late-life depression (LLD) is increasingly recognized as a complex multisystem disorder associated with accelerated biological aging, impaired physiological resilience, frailty, and an increased risk of cognitive decline and dementia. Although growing evidence supports the close relationship between depression, frailty, and neurodegeneration, the molecular mechanisms underlying this continuum remain incompletely understood. In particular, conventional clinical and imaging biomarkers capture established disease but provide limited insight into the systemic biological processes that precede neurodegeneration. Proteomics has emerged as a powerful systems biology approach capable of characterizing the dynamic molecular networks involved in aging, neuropsychiatric disorders, and neurodegenerative diseases. Recent advances in high-throughput mass spectrometry have identified alterations in proteins associated with chronic inflammation, complement activation, mitochondrial dysfunction, oxidative stress, lipid metabolism, synaptic integrity, neurotrophic signaling, and cellular senescence across LLD, frailty, cognitive impairment, and Alzheimer’s disease (AD). These convergent proteomic signatures suggest that these conditions may share common biological pathways consistent with progressive loss of physiological resilience rather than independent pathological entities. In this review, we examine the current evidence supporting shared proteomic mechanisms linking LLD, frailty, cognitive frailty (CF), and neurodegeneration. We discuss the potential integration of large-scale proteomic profiling with established AD biomarkers within the AT(N) framework to improve biological characterization, early risk stratification, and prediction of cognitive decline. Particular emphasis is placed on CF as a transitional and potentially modifiable phenotype in which systemic molecular dysregulation precedes overt neurodegeneration. By integrating evidence from geroscience, neuropsychiatry, and proteomics, we propose that proteomic profiling can redefine LLD and frailty as manifestations of a common biological vulnerability continuum. This systems-level perspective may facilitate the identification of individuals at high risk for dementia, support the development of multimodal biomarker panels, and advance precision neuropsychiatry through earlier diagnosis and personalized preventive interventions.

Authors

Publication Details

Journal
Proteomes
Published
2026-11-17
DOI
https://doi.org/10.3390/proteomes14040061
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Proteomic Signatures of Vulnerability Across Late-Life Depression, Frailty, and Neurodegeneration

Emanuela Resta, Anita Mollica, Antonello Bellomo, Mario Altamura et al.
3 links
Proteomes
Dementia and Cognitive Impairment Research
article

Proteomic Signatures of Vulnerability Across Late-Life Depression, Frailty, and Neurodegeneration

Emanuela Resta, Anita Mollica, Antonello Bellomo, Mario Altamura, Francesco Panza, Ivana Leccisotti, Iris Bonfitto, Angelo De Giorgi, Maria Claudia Moretti, Rossana Laurello, Michele Carapellese, Madia Lozupone
article en

Abstract

Late-life depression (LLD) is increasingly recognized as a complex multisystem disorder associated with accelerated biological aging, impaired physiological resilience, frailty, and an increased risk of cognitive decline and dementia. Although growing evidence supports the close relationship between depression, frailty, and neurodegeneration, the molecular mechanisms underlying this continuum remain incompletely understood. In particular, conventional clinical and imaging biomarkers capture established disease but provide limited insight into the systemic biological processes that precede neurodegeneration. Proteomics has emerged as a powerful systems biology approach capable of characterizing the dynamic molecular networks involved in aging, neuropsychiatric disorders, and neurodegenerative diseases. Recent advances in high-throughput mass spectrometry have identified alterations in proteins associated with chronic inflammation, complement activation, mitochondrial dysfunction, oxidative stress, lipid metabolism, synaptic integrity, neurotrophic signaling, and cellular senescence across LLD, frailty, cognitive impairment, and Alzheimer’s disease (AD). These convergent proteomic signatures suggest that these conditions may share common biological pathways consistent with progressive loss of physiological resilience rather than independent pathological entities. In this review, we examine the current evidence supporting shared proteomic mechanisms linking LLD, frailty, cognitive frailty (CF), and neurodegeneration. We discuss the potential integration of large-scale proteomic profiling with established AD biomarkers within the AT(N) framework to improve biological characterization, early risk stratification, and prediction of cognitive decline. Particular emphasis is placed on CF as a transitional and potentially modifiable phenotype in which systemic molecular dysregulation precedes overt neurodegeneration. By integrating evidence from geroscience, neuropsychiatry, and proteomics, we propose that proteomic profiling can redefine LLD and frailty as manifestations of a common biological vulnerability continuum. This systems-level perspective may facilitate the identification of individuals at high risk for dementia, support the development of multimodal biomarker panels, and advance precision neuropsychiatry through earlier diagnosis and personalized preventive interventions.

ProteomesVol. 14(4)
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon